Electronic Notification of Teratogenic Risks
- Conditions
- TeratogensAbnormalities, Drug-InducedContraception
- Registration Number
- NCT00766207
- Lead Sponsor
- University of Pittsburgh
- Brief Summary
This study will use a factorial design randomized controlled trial to (1)compare multi-faceted decision support (intervention) to streamlined clinical alerts (control) and (2) evaluate whether collecting information about women's risk of pregnancy using a networked tablet computer (intervention) is superior to the way clinicians usually collect this information (control).
Over the course of 1 year, we will abstract data from the electronic medical record when study clinicians prescribe teratogenic medications, conduct phone interviews with women prescribed medications by participating clinicians, and survey participating clinicians about their satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction with the counseling they received, and (4) report more satisfaction with the decision support they received.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 2593
- Women aged 18-45 seen at a participating primary care clinic
- Non-English speakers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Proportion of women prescribed potentially teratogenic medications with documented use of contraception 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Partners in Health
🇺🇸Murrysville, Pennsylvania, United States
General Internal Medicine Oakland (GIMO) Practice
🇺🇸Pittsburgh, Pennsylvania, United States
Partners in Health🇺🇸Murrysville, Pennsylvania, United States